Follow
Tanuja N Gengiah, PhD
Tanuja N Gengiah, PhD
Researcher, CAPRISA, University of KwaZulu-Natal
Verified email at ukzn.ac.za
Title
Cited by
Cited by
Year
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
Q Abdool Karim, SS Abdool Karim, JA Frohlich, AC Grobler, C Baxter, ...
science 329 (5996), 1168-1174, 2010
30392010
Timing of initiation of antiretroviral drugs during tuberculosis therapy
SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ...
New England Journal of Medicine 362 (8), 697-706, 2010
9122010
Integration of antiretroviral therapy with tuberculosis treatment
SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, AL Gray, ...
New England Journal of Medicine 365 (16), 1492-1501, 2011
6372011
Tenofovir gel for the prevention of herpes simplex virus type 2 infection
SS Abdool Karim, Q Abdool Karim, ABM Kharsany, C Baxter, AC Grobler, ...
New England Journal of Medicine 373 (6), 530-539, 2015
1162015
Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study
A Moosa, TN Gengiah, L Lewis, K Naidoo
BMC infectious diseases 19, 1-12, 2019
872019
Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness
ADM Kashuba, TN Gengiah, L Werner, KH Yang, NR White, QA Karim, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 264-269, 2015
872015
The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis
TN Gengiah, NHG Holford, JH Botha, AL Gray, K Naidoo, ...
European journal of clinical pharmacology 68, 689-695, 2012
642012
Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection
TN Gengiah, A Moosa, A Naidoo, LE Mansoor
International journal of clinical pharmacy 36, 70-85, 2014
582014
A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa
F van Loggerenberg, D Gray, S Gengiah, P Kunene, TN Gengiah, ...
AIDS patient care and STDs 29 (5), 299-306, 2015
572015
Low rifampicin concentrations in tuberculosis patients with HIV infection
TN Gengiah, JH Botha, D Soowamber, K Naidoo, SSA Karim
The Journal of Infection in Developing Countries 8 (08), 987-993, 2014
432014
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
QA Karim, ABM Kharsany, JA Frohlich, C Baxter, N Yende, LE Mansoor, ...
Trials 12, 1-8, 2011
412011
A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection
TN Gengiah, C Baxter, LE Mansoor, ABM Kharsany, SS Abdool Karim
Expert opinion on investigational drugs 21 (5), 695-715, 2012
322012
Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study …
S Mahomed, N Garrett, QA Karim, NY Zuma, E Capparelli, C Baxter, ...
BMJ open 10 (11), e042247, 2020
282020
Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART
B Maharaj, TN Gengiah, N Yende-Zuma, S Gengiah, A Naidoo, K Naidoo
The International Journal of Tuberculosis and Lung Disease 21 (5), 537-543, 2017
282017
Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: Findings of the …
F van Loggerenberg, AD Grant, K Naidoo, M Murrman, S Gengiah, ...
AIDS and behavior 19, 145-156, 2015
282015
Changes to antiretroviral drug regimens during integrated TB–HIV treatment: results of the SAPiT trial
A Naidoo, K Naidoo, N Yende-Zuma, TN Gengiah, N Padayatchi, AL Gray, ...
Antiviral therapy 19 (2), 161-169, 2014
282014
Initiating antiretrovirals during tuberculosis treatment: a drug safety review
TN Gengiah, AL Gray, K Naidoo, QA Karim
Expert opinion on drug safety 10 (4), 559-574, 2011
282011
Co-enrollment in multiple HIV prevention trials—Experiences from the CAPRISA 004 Tenofovir gel trial
QA Karim, ABM Kharsany, K Naidoo, N Yende, T Gengiah, Z Omar, ...
Contemporary clinical trials 32 (3), 333-338, 2011
282011
CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide …
TN Gengiah, QA Karim, I Harkoo, L Mansoor, NY Zuma, P Radebe, ...
BMJ open 12 (1), e052880, 2022
172022
Assessing adherence to antiretroviral therapy in a rural paediatric cohort in KwaZulu-Natal, South Africa
C Smith, TN Gengiah, N Yende-Zuma, M Upfold, K Naidoo
AIDS and Behavior 20, 2729-2738, 2016
172016
The system can't perform the operation now. Try again later.
Articles 1–20